BACE1 inhibitors: A head group scan on a series of amides
Thomas J. Woltering(Roche (Switzerland)), Robert Narquizian(Roche (Switzerland)), A. Mayweg(Roche (Switzerland)), Wolfgang Guba(Roche (Switzerland)), Martina Pollastrini(Siena Biotech (Italy)), Massimiliano Travagli(Siena Biotech (Italy)), Mark Rogers‐Evans(Roche (Switzerland)), Emmanuel Pinard(Roche (Switzerland)), Wolfgang Wostl(Roche (Switzerland)), Harald Mauser(Roche (Switzerland)), Helmut Jacobsen(Roche (Switzerland)), G. Marconi(Siena Biotech (Italy)), Eoin Power(Siena Biotech (Italy)), Emanuele Gabellieri(Siena Biotech (Italy)), Matteo Andreini(Siena Biotech (Italy)), Jörg Benz(Roche (Switzerland)), Martin Göbel(Roche (Switzerland)), David W. Banner(Roche (Switzerland)), Hans Hilpert(Roche (Switzerland))
Cited by 52
Related Papers
Fluorine in Medicinal Chemistry
|ChemBioChem|2004|1.5k
Oxetanes as Versatile Elements in Drug Discovery and Synthesis
|Angewandte Chemie International Edition|2010|435
Oxetanes in Drug Discovery: Structural and Synthetic Insights
|Journal of Medicinal Chemistry|2010|405
Structure-Based Design and Synthesis of Potent Cyclic Peptides Inhibiting the YAP–TEAD Protein–Protein Interaction
|ACS Medicinal Chemistry Letters|2014|174
Prospective Evaluation of Free Energy Calculations for the Prioritization of Cathepsin L Inhibitors
|Journal of Medicinal Chemistry|2017|141